𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Focal amplification and oncogene dependency of GAB2 in breast cancer

✍ Scribed by Bocanegra, M; Bergamaschi, A; Kim, Y H; Miller, M A; Rajput, A B; Kao, J; Langerød, A; Han, W; Noh, D -Y; Jeffrey, S S


Book ID
109971150
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
581 KB
Volume
29
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Assessing sequential oncogene amplificat
✍ Laura E. Janocko; Joseph F. Lucke; David W. Groft; Kathryn A. Brown; Charles A. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

## Abstract Studies of amplification and/or overexpression of c‐myc, HER‐2/neu, and H‐ras in breast cancer have shown that each is associated with a poor prognosis. The purpose of this study was to explore the possibility that there is a preferred sequence of amplification of these oncogenes in bre

The significance of oncogene amplificati
✍ R. Seshadri; C. Matthews; A. Dobrovic; D. J. Horsfall 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 311 KB

Alterations in the gene copy numbers of the proto-oncogenes HERZ/neu and c-myc in primary human breast cancer investigated in 73 patients. We detected amplification of H€R2/ neu in 17 patient samples and amplification of c-myc in I I, while amplification of both was seen in 6 samples. There was no c

int-2 Oncogene amplification and prognos
✍ Laura Fioravanti; Vera Cappelletti; Danila Coradini; Patrizia Miodini; Giorgio B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months. Tumours had been previously characterised

The relative prognostic significance of
✍ Ram Seshadri; David J. Horsfall; Frank Firgaira; Kieran McCaul; Vittal Setlur; A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

Total tumor cathepsin D (TCD) levels were determined prospectively by a radioimmunometric assay in tumor c y t o d of 858 primary breast cancer patients diagnosed between 1989-1991. In 581 of these patients, tumor HER-l/neu oncogene amplification was simultaneously determined. In a "traininset" of 3